Cerebral venous sinus thrombosis (CVST) is a subtype of cerebral stroke, with an annual incidence of approximately 3–4 cases per million population [1]. Unlike other types of stroke, CVST typically occurs in young adults (mean age at onset: 35 years) [2]. In general, patients with CVST have a fair prognosis. Previous studies have shown that 60–79% of patients achieve good functional outcomes [Modified Rankin Scale (mRS) score 0–1) [3–4]. However, occurrence of seizures in these patients may adversely affect the prognosis; in one study, CVST patients with seizures were found to experience two-fold higher mortality rates as compared to their counterparts who did not develop seizures [5].
SEP